Clinical reference Biomarker Directory
Back to directory

Anti-Smith Antibodies

Established

Anti-Sm is a highly specific but insensitive autoantibody marker for lupus.

Also known as Anti-Sm anti-Smith antibody
In plain language

Anti-Sm is a specific blood marker for lupus. If it's positive, lupus is very likely, but a negative test doesn't rule it out since many lupus patients never develop this particular antibody.

Biomarker & context

Anti-Smith (anti-Sm) antibodies target small nuclear ribonucleoproteins and are highly specific autoantibodies associated with systemic lupus erythematosus (SLE), though they occur in only a minority of SLE patients.

What it indicates

Presence of anti-Sm strongly supports an SLE diagnosis due to its high specificity, though its sensitivity is low; it is one of two "SLE-specific antibody" markers (with anti-dsDNA) in current classification criteria.

Diagnosis & clinical testing

Measured via immunoassay as part of an extractable nuclear antigen (ENA) panel; the 2019 EULAR/ACR SLE classification criteria require a positive ANA (≥1:80) as a mandatory entry criterion before anti-Sm or anti-dsDNA can contribute additional points toward classification.

Guiding treatment

Anti-Sm status does not typically guide specific treatment choices but supports diagnostic certainty and is used in research classification of SLE cohorts and clinical trial eligibility.

Clinical significance

One of two SLE-specific serologic markers in current classification criteria (with anti-dsDNA).

References
  1. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology.